Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka

Details

• Alternative Title:
  J Infect Dis
• Personal Author:
  Gamage, Deepa ; Mach, Ondrej ; Ginige, Samitha ; Weldon, William C. ; Oberste, M. Steven ; Jeyaseelan, Visalakshi ; Sutter, Roland W.
• Description:
  Background.
  
  In July 2016, Sri Lanka replaced 1 intramuscular dose of inactivated poliovirus vaccine (IPV) with 2 doses of intradermal fractional-dose IPV (fIPV) in its routine immunization schedule. We carried out a survey of seroprevalence of antipolio antibodies in children who received 2 fIPV doses and compared it with those who received 1 full IPV dose.
  
  Methods.
  
  Children born between March and December 2016 were randomly selected from 3 Sri Lankan districts (Colombo, Badulla, and Anuradhapura). Serum samples were collected and tested for presence of neutralizing antibodies to poliovirus types 1, 2, and 3.
  
  Results.
  
  Seroprevalence of antipolio antibodies was 100% in all districts for poliovirus type 1 and poliovirus type 3; it ranged between 90% and 93% for poliovirus type 2 (PV2) in children who received 1 full IPV dose and between 78% and 100% in those receiving 2 fIPV doses (P = .22). The median reciprocal titers of anti-PV2 antibodies were similar in children who received full-dose IPV and those who received fIPV (1:64 vs 1:45, respectively; P = .11).
  
  Conclusions.
  
  Our study demonstrated not only that Sri Lanka succeeded in maintaining very high primary immunization coverage also but that it is feasible for a national immunization program to implement fIPV immunization and achieve high coverage with intradermal application. The seroprevalence of anti-PV2 antibodies did not decrease after the introduction of fIPV.
  
  
• Subjects:
  Adolescent Adult Antibodies, Neutralizing Antibodies, Viral Child Cross-Sectional Studies Female Humans Male Poliomyelitis Poliovirus Poliovirus Vaccine, Inactivated Seroepidemiologic Studies Young Adult

  More +
• Source:
  J Infect Dis. 219(12):1887-1892
• Pubmed ID:
  30649505
• Pubmed Central ID:
  PMC9201667
• Document Type:
  Journal Article
• Funding:
  001/WHO_/World Health OrganizationInternational/ ; CC999999/ImCDC/Intramural CDC HHSUnited States/
• Place as Subject:
  Sri Lanka
• Volume:
  219
• Issue:
  12
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:ac4fa8f22d59fbb83b3f762180a5ffdbf8172dd22a7c24da21a3c92f19e618ac
• Download URL:
  https://stacks.cdc.gov/view/cdc/119276/cdc_119276_DS1.pdf
• File Type:
  [PDF - 693.16 KB ]